Skip to main content

Lung, Primary Malignancies

Anila Khaliq, MD Reviewed 04/2024
 


BASICS

DESCRIPTION

  • Primary lung cancers are the leading cause of cancer-related deaths in the United States (estimated 130,180 deaths in 2021 which accounts for 25%% of all cancer-related deaths). Lung...

DIAGNOSIS

HISTORY

  • May be asymptomatic for most of course

  • Respiratory

    • Cough (new or change in chronic cough)

    • Wheezing and stridor

    • Dyspnea

    • Hemoptysis

    • Pneumonitis (fever and productive cough)

  • Constitutional

    • Malai...

TREATMENT

GENERAL MEASURES

  • NSCLC

    • Stage I, stage II, and selected stage III tumors are surgically resectable. Neoadjuvant or adjuvant therapy is recommended for select patients with high risk IB, II, and...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

Visits every 3 to 6 months in the first 2 years after surgery with physical exam and CT scan 

PATIENT EDUCATION

REFERENCES

1
US Preventive Services Task Force, Krist AH, Davidson KW, et al. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10):962-970. 

CODES

ICD10

  • C34.90 Malignant neoplasm of unsp part of unsp bronchus or lung

  • C34.10 Malignant neoplasm of upper lobe, unsp bronchus or lung

  • C34.30 Malignant neoplasm of lower lobe, unsp bronchus or lung

  • C3...

CLINICAL PEARLS

  • NSCLC (>85% of all lung cancers); normally originate in periphery

    • Adenocarcinoma (~40% of NSCLC); SCC (~25% of NSCLC); Large cell (~10% of NSCLC)

  • SCLC centrally located, early metasta...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×